Skip to main content

BP Directors, LP's Form 4 filing

Actuate Therapeutics, Inc.ACTU · filed Jun 30, 2025

Accession no.
0001104659-25-063993
Filed
Jun 30, 2025, 1:03 PM ET
Trade date
Jun 27, 2025
Filing delay
3 days
Rule 10b5-1 plan
Not checked

This filing lists 1 non-derivative transaction and 1 derivative transaction. Open-market purchases total $500.0K. It was filed 3 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
BP Directors, LPCIK 0001813311Director, 10% Owner
Bios Clinical Opportunity Fund, LPCIK 0001988639Director, 10% Owner
Bios Equity COF, LPCIK 0002000747Director, 10% Owner
Bios 2024 Co-Invest, LPCIK 0002028708Director, 10% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 27, 2025Common StockPPurchaseAcquired+71,428$7.00+$499,996196,428IndirectDuplicate filing

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jun 27, 2025Common StockPPurchaseAcquired+71,428$0.00$071,428IndirectDuplicate filing

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Remarks

Exhibit 24 - Power of Attorney Each of the reporting persons may be deemed a "director by deputization" as the result of Aaron G.L. Fletcher's position as a director of the Issuer. This Form 4 is the third of three Forms 4 filed relating to the same event. The Form 4 has been split into three filings because there are more than 10 reporting persons in total, and the SEC's EDGAR filing system limits a single Form 4 to a maximum of 10 reporting persons. The first Form 4 was filed by Leslie W. Kreis as the designated filer. The second Form 4 was filed by Aaron G.L. Fletcher as the designated filer.

Read the full filing on SEC EDGAR (opens in a new tab)